SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX -- Ignore unavailable to you. Want to Upgrade?

To: john dodson who wrote (1517)1/20/2000 12:28:00 PM
From: Austin S.  Read Replies (1) | Respond to of 1754
 
Opinion: VISX will be back at $39 inside of two weeks and will hover in the $39 - $44 range until next Qtr.'s earnings. VISX will be trading in the $75 - $85 range inside of 12 months. This giant will not be denied. The market is ripe, competition is good, and VISX by no means needs to retain anywhere near its current 75% market share to succeed.



To: john dodson who wrote (1517)1/20/2000 12:30:00 PM
From: Krikor  Read Replies (2) | Respond to of 1754
 
Hi John,

I still believe it will rebound and the price could be in the 40's. What is interesting is that they had a record quarter earnings followed by a deluge of 4 downgrades. I think the same people that downgraded it are buying it now.

As far as their business is concerned, they will probably lower the licensing fee and will have competition, but I don't believe doctors will change systems overnight.

PS: I did buy some today @ 30.50

Regards,
KG


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News